Disc Medicine, Inc.
- IRON
- NASDAQ
- Biotechnology
- Hematology Therapeutics
- Clinical-Stage Biotech
$78.93
Today +38.86%Quote Oct 19, 2026, 08:00 PM UTC
+13.52%over the last month
Max drawdown −19.8%From 1-month high 0.0%3 months +4.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Disc Medicine
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
165
Market value
$3.03B
Quote Oct 19
Floor
$72.08
8.7% below price
Resistance
$81.17
2.8% above price
Price vs analyst targets
11 analysts
Lowest target
$86.00Highest target
$128.00
$86.00Highest target
$128.00
- Price $78.93
- Average target $109.83
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 39% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about IRONPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free